Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016579; protein deubiquitination | 3.301E-08 | 1.797E-05 | AR, CFTR, ESR1, HIF1A, TNKS, TNKS2, TP53, USP2 |
BP | Unclassified; | GO:0032846; positive regulation of homeostatic process | 1.392E-07 | 5.562E-05 | CFTR, HIF1A, NPC1, PTGS2, SYK, TNKS, TNKS2 |
BP | GO:0008152; metabolic process | GO:2000379; positive regulation of reactive oxygen species metabolic process | 5.706E-07 | 1.750E-04 | MAPT, NOX4, PTGS2, TP53, XDH |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 6.483E-07 | 1.908E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0032501; multicellular organismal process | GO:0060736; prostate gland growth | 8.903E-07 | 2.423E-04 | AR, CYP19A1, ESR1 |
BP | Unclassified; | GO:0032844; regulation of homeostatic process | 1.655E-06 | 3.960E-04 | CDK6, CFTR, HIF1A, NPC1, PTGS2, SYK, TNKS, TNKS2 |
BP | GO:0008283; cell proliferation | GO:0008284; positive regulation of cell proliferation | 2.551E-06 | 5.787E-04 | AR, CDK6, CSNK2A1, ESR1, FLT3, HIF1A, PTGS2, SYK, THPO, TSHR |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 6.424E-06 | 1.260E-03 | CYP1A1, HIF1A, NOX4, PKM, PTGS2, TP53 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 7.088E-06 | 1.378E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 9.415E-06 | 1.720E-03 | CYP1A1, CYP1A2, CYP1B1 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 6.933E-10 | 8.597E-08 | HSD17B1; CYP1A2; CYP1A1; CYP1B1; CYP3A4; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.965E-05 | 4.086E-04 | CYP1A2; XDH |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 6.866E-07 | 2.129E-05 | MAOA; CYP1A2; CYP1A1; CYP1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 5.267E-03 | 1.881E-02 | ALOX15; PTGS2 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.739E-05 | 2.695E-04 | CYP1A2; ALOX15; CYP3A4 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.991E-04 | 1.646E-03 | CYP1A2; CYP1A1; CYP3A4 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 7.850E-06 | 1.390E-04 | CYP1A2; CYP1A1; CYP1B1; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.377E-04 | 1.842E-03 | MAOA; CYP1A2; CYP3A4 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.934E-03 | 1.299E-02 | CYP3A4; XDH |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 3.537E-05 | 4.386E-04 | PKM; MAOA; HSD17B1; CYP1A2; ALOX15; CYP1A1; PTGS2; CYP3A4; CYP19A1; XDH |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | HIV-associated diarrhoea | A09 | CFTR |
A00-B99: Certain infectious and parasitic diseases | Human immunodeficiency virus infection | B20-B26 | FLT3 |
A00-B99: Certain infectious and parasitic diseases | Diarrhea | A09, K59.1 | CFTR |
A00-B99: Certain infectious and parasitic diseases | Trematode infection | B66.9 | ESR1 |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Acute lymphoblastic leukemia | C91.0 | FLT3 |
C00-D49: Neoplasms | CLL | NA | FLT3 |
C00-D49: Neoplasms | Cancer | C00-C96 | AR; GSK3B; HIF1A; SYK; TP53; FLT3; FLT3; ACHE; ESR1; ESR1; PTGS2; CSNK2A1 |